Benfotiamine increases transketolase activity, that can in turn decreases the buildup of detrimental glucose metabolites that can lead to advanced glycation end products (AGE), which may lead to diabetic complications. Benfotiamine also prevents diabetic retinopathy. Benfotiamine and alpha-lipoic acid should be considered as first choices among pathogenetically oriented treatments of diabetic neuropathy. Gama-Linoleic acid improves glucose metabolism & enhances muscle insulin sensitivity. It reduces blood glucose levels and HbA1c in patients with type 2 diabetes.
How to use
As directed by phsician
Interactions / Warnings
Use under medical supervision.
Uses / Indications
This Medicine isindicated in Diabetic Neuropathy, Diabetic Nephropathy, Diabetic retinopathy, CVD and Alcoholic Neuropathy
